Full Breakdown
Newborn Screening for Spinal Muscular Atrophy: Wales Remains Excluded
8/10/2026, 9:41:28 PM
Background and Policy Context
Routine newborn screening for spinal muscular atrophy (SMA) has recently been introduced across England and is being piloted in Scotland, while the same testing is not in place in Wales or Northern Ireland. The UK National Screening Committee (NSC) has not recommended routine SMA screening for the whole United Kingdom, a guidance that the Welsh government says it follows.
Parental Concerns and Advocacy
Parents of children with SMA in Wales argue that the lack of routine screening leaves the nation behind other parts of the UK. Warren Davies, whose three-year-old daughter Ophelia-May has SMA type 2, expressed frustration that the Welsh government is choosing not to act despite having the capacity to change outcomes. Campaigns for screening have been amplified by public figures, including former Little Mix singer Jesy Nelson, who have highlighted the disparity.
Official Government Position
The Welsh government responded that its policy aligns with the NSC’s current recommendation, which does not endorse universal newborn SMA screening. Officials indicated that any change would require a revision of the committee’s guidance before Wales could implement routine testing.
Potential Impact and Next Steps
The absence of screening means that Welsh infants with SMA are diagnosed after the onset of symptoms, potentially delaying early-intervention treatments that are more effective when started promptly. Advocates hope that future updates to NSC guidance will prompt the Welsh authorities to adopt routine screening, bringing Wales in line with England’s established program and Scotland’s trial. Until such guidance changes, the current situation is likely to persist, maintaining the regional disparity in early SMA detection across the United Kingdom.
